These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 26215400

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
    Brites D.
    Ann Hepatol; 2002; 1(1):20-8. PubMed ID: 15114292
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.
    Bacq Y, Sentilhes L, Reyes HB, Glantz A, Kondrackiene J, Binder T, Nicastri PL, Locatelli A, Floreani A, Hernandez I, Di Martino V.
    Gastroenterology; 2012 Dec; 143(6):1492-501. PubMed ID: 22892336
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy.
    Geenes V, Chambers J, Khurana R, Shemer EW, Sia W, Mandair D, Elias E, Marschall HU, Hague W, Williamson C.
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():59-63. PubMed ID: 25864112
    [Abstract] [Full Text] [Related]

  • 29. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial.
    Floreani A, Paternoster D, Melis A, Grella PV.
    Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):109-13. PubMed ID: 8841797
    [Abstract] [Full Text] [Related]

  • 30. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis.
    Roncaglia N, Locatelli A, Arreghini A, Assi F, Cameroni I, Pezzullo JC, Ghidini A.
    BJOG; 2004 Jan; 111(1):17-21. PubMed ID: 14687046
    [Abstract] [Full Text] [Related]

  • 31. [Clinical practice guidelines of the Team of Experts of the Polish Gynecological Society: management of the intrahepatic cholestasis of pregnancy].
    Leszczyńska-Gorzelak B, Oleszczuk J, Marciniak B, Poreba R, Oszukowski P, Wielgoś M, Czajkowski K, Zespoł Ekspertów Polskiego Towarzystwa Ginekologicznego.
    Ginekol Pol; 2012 Sep; 83(9):713-7. PubMed ID: 23342903
    [Abstract] [Full Text] [Related]

  • 32. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
    Binder T, Salaj P, Zima T, Vítek L.
    J Perinat Med; 2006 Sep; 34(5):383-91. PubMed ID: 16965225
    [Abstract] [Full Text] [Related]

  • 33. Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes.
    Yang J, Chen C, Liu M, Zhang S.
    Medicine (Baltimore); 2019 Jul; 98(27):e16214. PubMed ID: 31277130
    [Abstract] [Full Text] [Related]

  • 34. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D, Rodrigues CM, Oliveira N, Cardoso M, Graça LM.
    J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
    [Abstract] [Full Text] [Related]

  • 35. Role of ursodeoxycholic acid on maternal serum bile acids and perinatal outcomes in intrahepatic cholestasis of pregnancy.
    Roy A, Premkumar M, Mishra S, Mehtani R, Suri V, Aggarwal N, Singh S, Dhiman RK.
    Eur J Gastroenterol Hepatol; 2021 Apr 01; 33(4):571-576. PubMed ID: 33136720
    [Abstract] [Full Text] [Related]

  • 36. Intrahepatic cholestasis of pregnancy: a French prospective study.
    Bacq Y, Sapey T, Bréchot MC, Pierre F, Fignon A, Dubois F.
    Hepatology; 1997 Aug 01; 26(2):358-64. PubMed ID: 9252146
    [Abstract] [Full Text] [Related]

  • 37. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels.
    Brouwers L, Koster MP, Page-Christiaens GC, Kemperman H, Boon J, Evers IM, Bogte A, Oudijk MA.
    Am J Obstet Gynecol; 2015 Jan 01; 212(1):100.e1-7. PubMed ID: 25046809
    [Abstract] [Full Text] [Related]

  • 38. [Influence of pharmacological treatment on selected parameters of intrahepatic cholestasis of pregnancy].
    Brzozowska M, Kowalska-Koprek U, Karowicz-Bilińska A.
    Ginekol Pol; 2010 Feb 01; 81(2):94-8. PubMed ID: 20232705
    [Abstract] [Full Text] [Related]

  • 39. Fetal PR Interval in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case-Control Study.
    Guerra M, Montaño I, Haye MT, Toro V, Maiz N.
    Am J Perinatol; 2024 May 01; 41(S 01):e2964-e2969. PubMed ID: 37774745
    [Abstract] [Full Text] [Related]

  • 40. Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine.
    Glantz A, Reilly SJ, Benthin L, Lammert F, Mattsson LA, Marschall HU.
    Hepatology; 2008 Feb 01; 47(2):544-51. PubMed ID: 17968976
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.